Biology Reference
In-Depth Information
Dumuis, A., Bouhelal, R., Sebben, M., Cory, R., & Bockaert, J. (1988). A nonclassical
5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central
nervous system. Molecular Pharmacology , 34 (6), 880-887.
Gorinski, N., Kowalsman, N., Renner, U., Wirth, A., Reinartz, M. T., Seifert, R., et al. (2012).
Computational and experimental analysis of the transmembrane domain 4/5 dimerization
interface of the serotonin 5-HT(1A) receptor. Molecular Pharmacology , 82 (3), 448-463.
http://dx.doi.org/10.1124/mol.112.079137 .
Herrick-Davis, K., Grinde, E., Harrigan, T. J., & Mazurkiewicz, J. E. (2005). Inhibition of se-
rotonin 5-hydroxytryptamine2c receptor function through heterodimerization: Receptor
dimers bind two molecules of ligand and one G-protein. Journal of Biological Chemistry ,
280 (48), 40144-40151.
Herrick-Davis, K., Grinde, E., & Mazurkiewicz, J. E. (2004). Biochemical and biophysical
characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of
living cells. Biochemistry , 43 (44), 13963-13971. http://dx.doi.org/10.1021/bi048398p .
Kristiansen, K., Kroeze, W. K., Willins, D. L., Gelber, E. I., Savage, J. E., Glennon, R. A., et al.
(2000). A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of
tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but
does not participate in activation via a “salt-bridge disruption” mechanism. Journal of
Pharmacology and Experimental Therapeutics , 293 (3), 735-746.
Lee, S. P., Xie, Z., Varghese, G., Nguyen, T., O'Dowd, B. F., & George, S. R. (2000). Olig-
omerization of dopamine and serotonin receptors. Neuropsychopharmacology , 23 (4
Suppl), S32-S40. http://dx.doi.org/10.1016/S0893-133X(00)00155-X .
Lukasiewicz, S., Faron-Gorecka, A., Kedracka-Krok, S., & Dziedzicka-Wasylewska, M.
(2011). Effect of clozapine on the dimerization of serotonin 5-HT(2A) receptor and its ge-
netic variant 5-HT(2A)H425Y with dopamine D(2) receptor. European Journal of Phar-
macology , 659 (2-3), 114-123. http://dx.doi.org/10.1016/j.ejphar.2011.03.038 .
Maurel, D., Kniazeff, J., Mathis, G., Trinquet, E., Pin, J. P., & Ansanay, H. (2004). Cell
surface detection of membrane protein interaction with homogeneous time-resolved
fluorescence resonance energy transfer technology. Analytical Biochemistry , 329 (2),
253-262.
Millan, M. J., Marin, P., Bockaert, J., & Mannoury la Cour, C. (2008). Signaling at G-protein-
coupled serotonin receptors: Recent advances and future research directions. Trends in
Pharmacological Sciences , 29 (9), 454-464. http://dx.doi.org/10.1016/j.tips.2008.06.007 .
Pellissier, L. P., Barthet, G., Gaven, F., Cassier, E., Trinquet, E., Pin, J. P., et al. (2011).
G protein activation by serotonin type 4 receptor dimers: Evidence that turning on two
protomers is more efficient. Journal of Biological Chemistry , 286 (12), 9985-9997.
http://dx.doi.org/10.1074/jbc.M110.201939 .
Renner, U., Zeug, A., Woehler, A., Niebert, M., Dityatev, A., Dityateva, G., et al. (2012). Het-
erodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates recep-
tor signalling and trafficking. Journal of Cell Science , 125 (Pt 10), 2486-2499. http://dx.
doi.org/10.1242/jcs.101337 .
Srinivasan, S., Santiago, P., Lubrano, C., Vaisse, C., & Conklin, B. R. (2007). Engineering the
melanocortin-4 receptor to control constitutive and ligand-mediated G(S) signaling in
vivo. PLoS One , 2 (7), e668. http://dx.doi.org/10.1371/journal.pone.0000668 .
Strader, C. D., Gaffney, T., Sugg, E. E., Candelore, M. R., Keys, R., Patchett, A. A., et al.
(1991). Allele-specific activation of genetically engineered receptors. Journal of Biolog-
ical Chemistry , 266 (1), 5-8.
Search WWH ::




Custom Search